Current Challenges in Yersinia Diagnosis and Treatment
Open Access
- 15 May 2025
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 13 (5) , 1133
Abstract
Yersinia bacteria (Yersinia enterocolitica, Yersinia pseudotuberculosis) are commonly found in nature in all climatic zones and are isolated from food (mainly raw pork, unpasteurized milk, or contaminated water), soil, and surface water, rarely from contaminated blood. Yersinia infection occurs through sick or asymptomatic carriers and contact with the feces of infected animals. The invasion of specific bacterial serotypes into the host cell is based on the type 3 secretion system (T3SS), which directly introduces many effector proteins (Yersinia outer proteins—Yops) into the host cell. The course of yersiniosis can be acute or chronic, with the predominant symptoms of acute enteritis (rarely pseudo-appendicitis or septicemia develops). Clinical and laboratory diagnosis of yersiniosis is difficult. The infection requires confirmation by isolating Yersinia bacteria from feces or other biological materials, including lymph nodes, synovial fluid, urine, bile, or blood. The detection of antibodies in blood serum or synovial fluid is useful in the diagnostic process. The treatment of yersiniosis is mainly symptomatic. Uncomplicated infections (diarrhea and abdominal pain) usually do not require antibiotic therapy, which is indicated in severe cases. Surgical intervention is undertaken in the situations of intestinal necrosis. Given the diagnostic and therapeutic difficulties, this review discusses the prevalence of Y. enterocolitica and Y. pseudotuberculosis, their mechanisms of disease induction (virulence factors and host response), clinical manifestations, diagnostic and preventive methods, and treatment strategies in the context of current knowledge and available recommendations.Keywords
This publication has 184 references indexed in Scilit:
- Endoscopic and video capsule endoscopic observation of Yersinia enterocolitisDEN Open, 2023
- Diversity of Yersinia enterocolitica isolated from pigs in a French slaughterhouse over 2 yearsMicrobiologyopen, 2018
- Tumor necrosis factor–inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor–driven model of rheumatoid arthritisArthritis & Rheumatism, 2012
- Antiinflammatory effect of Rho kinase blockade via inhibition of NF‐κB activation in rheumatoid arthritisArthritis & Rheumatism, 2008
- Complement activation by both classical and alternative pathways is critical for the effector phase of arthritisEuropean Journal of Immunology, 2004
- Molecular Epidemiology of the Five Recent Outbreaks of Yersinia pseudotuberculosis in Finland2004
- Molecular Epidemiology of Yersinia enterocolitica 4/O:32004
- Mechanisms of effects of complement inhibition in murine collagen‐induced arthritisArthritis & Rheumatism, 2002
- Report of four cases ofYersinia pseudotuberculosis septicemia and a literature reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Influence of antibiotics on IgA and IgG response and persistence ofYersinia enterocolitica in patients with yersinia-associated spondylarthropathyInfection, 1992